A rot mutation restores parental virulence to an agr-null Staphylococcus aureus strain in a rabbit model of endocarditis

Infection and Immunity

Volumn 73, Issue 6, 2005, Pages 3806-3809

  McNamara, Peter J ^a,d   Bayer, Arnold S ^b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIN;

AGR GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL ENDOCARDITIS; BACTERIAL GENE; BACTERIAL VIRULENCE; FEMALE; GENE MUTATION; IN VITRO STUDY; MUTANT; NONHUMAN; PRIORITY JOURNAL; RABBIT; ROT GENE; STAPHYLOCOCCUS AUREUS; WILD TYPE;

ANIMALS; BACTERIAL PROTEINS; ENDOCARDITIS, BACTERIAL; FEMALE; MUTATION; RABBITS; REPRESSOR PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS; VIRULENCE;

EID: 19744380666     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.6.3806-3809.2005     Document Type: Article

References (30)

1. Balaban, N., T. Goldkorn, Y. Gov, M. Hirshberg, N. Koyfman, H. R. Matthews, R. T. Nhan, B. Singh, and O. Uziel. 2001. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating protein (TRAP). J. Biol. Chem. 276:2658-2667.
2. Bayer, A. S., and D. C. Norman. 1997. Valve site-specific pathogenetic differences between right-sided and left-sided bacterial endocarditis. Chest 98:200-205.
3. Bayer, A. S., M. D. Ramos, B. E. Menzies, M. R. Yeaman, A. J. Shen, and A. L. Cheung. 1997. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect. Immun. 65:4652-4660.
4. Bhakdi, S., and J. Tranum-Jensen. 1991. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55:733-751.
5. Björklind, A., and S. Arvidson. 1980. Mutants of Staphylococcus aureus affected in the regulation of exoprotein synthesis. FEMS Microbiol. Lett. 7:203-206.
6. Bozdogan, B., and P. C. Appelbaum. 2004. Oxazolidinones: activity, mode of action, and mechanism of resistance. Int. J. Antimicrob. Agents 23:113-119.
7. - mutant of Staphylococcus aureus in the rabbit model of endocarditis. J. Clin. Investig. 94:1815-1822.
8. Cheung, A. L., and G. Zhang. 2002. Global regulation of virulence determinants in Staphylococcus aureus by the SarA protein family. Front. Biosci. 7:d1825-d1842.
9. Chien, C.-T., A. C. Mann, S. J. Projan, and A. L. Cheung. 1999. SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to conserved motif essential for sar-dependent gene regulation. J. Biol. Chem. 274:37169-37176.
10. Ji, G., R. Beavis, and R. P. Novick. 1997. Bacterial interference caused by autoinducing peptide variants. Science 276:2027-2030.
11. Korem, M., A. S. Sheoran, Y. Gov, S. Tzipori, I. Borovok, and N. Balaban. 2003. Characterization of RAP, a quorum sensing activator of Staphylococcus aureus. FEMS Microbiol. Lett. 223:167-175.
12. Kupferwasser, L. I., M. R. Yeaman, S. M. Shapiro, C. C. Nast, and A. S. Bayer. 2002. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation 105:746-752.
13. Lyon, G. J., P. Mayville, T. W. Muir, and R. P. Novick. 2000. Rational design of a global inhibitor of the virulence response in Staphylococcus aureus, based in part on localization of the site of inhibition to the receptor-histidine kinase, AgrC. Proc. Natl. Acad. Sci. USA 97:13330-13335.
14. Massey, R. C., S. R. Dissanayeke, B. Cameron, D. Ferguson, T. J. Foster, and S. J. Peacock. 2002. Functional blocking of Staphylococcus aureus adhesins following growth in ex vivo media. Infect. Immun. 70:5339-5345.
15. McDevitt, D., P. Francois, P. Vaudaux, and T. J. Foster. 1994. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol. 11:237-248.
16. McNamara, P. J., K. Milligan-Monroe, and R. A. Proctor. 2000. Identification, cloning, and initial characterization of rot, a locus encoding a repressor of extracellular toxins in Staphylococcus aureus. J. Bacteriol. 182:3197-3203.
17. Meka, V. G., S. K. Pillai, G. Sakoulas, C. Wennersten, L. Venkataraman, P. C. DeGirolami, G. M. Eliopoulos, R. C. Moellering, Jr., and H. S. Gold. 2004. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J. Infect. Dis. 190:311-317.
18. Moreillon, P., Y. A. Que, and A. S. Bayer. 2002. Pathogenesis of streptococcal and staphylococcal endocarditis. Infect. Dis. Clin. N. Am. 16:297-318.
19. Morfeldt, E., D. Taylor, A. von Gabain, and S. Arvidson. 1995. Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J. 14:4569-4577.
20. Ni Eidhin, D., S. Perkins, P. Francois, P. Vaudaux, M. Hook, and T. J. Foster. 1994. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol. Microbiol. 30:245-257.
21. Nilius, A. M. 2003. Have the oxazolidinones lived up to their billing? Future perspectives for this antibacterial class. Curr. Opin. Investig. Drugs 4:149-155.
22. Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48:1429-1449.
23. Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth, and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975.
24. O'Brien, L., S. W. Kerrigan, G. Kaw, M. Hogan, J. Penades, D. Litt, D. J. Fitzgerald, T. J. Foster, and D. Cox. 2002. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol. Microbiol. 44:1033-1044.
25. Otto, M. 2001. Staphylococcus aureus and Staphylococcus epidermidis peptide pheromones produced by the accessory gene regulator agr system. Peptides 22:1603-1608.
26. Otto, M., R. Sussmuth, C. Vuong, G. Jung, and F. Gotz. 1999. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett. 450:257-262.
27. Qiu, X. Q., H. Wang, X. F. Lu, J. Zhang, S. F. Li, G. Cheng, L. Wan, L. Yang, J. Y. Zuo, Y. Q. Zhou, H. Y. Wang, X. Cheng, S. H. Zhang, Z. R. Ou, Z. C. Zhong, J. Q. Cheng, Y. P. Li, and G. Y. Wu. 2003. An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria. Nat. Biotechnol. 21:1480-1485.
28. Saïd-Salim, B., P. M. Dunman, F. M. McAleese, D. Macapagal, E. Murphy, P. J. McNamara, S. Arvidson, T. J. Foster, S. J. Projan, and B. N. Kreiswirth. 2003. Global regulation of Staphylococcus aureus genes by Rot. J. Bacteriol. 185:610-619.
29. Xiong, Y.-Q., A. S. Bayer, M. R. Yeaman, W. van Wamel, A. C. Manna, and A. L. Cheung. 2004. Impacts of sarA and agr in Staphylococcus aureus strain Newman on fibronectin-binding protein A gene expression and fibronectin adherence capacity in vitro and in experimental infective endocarditis. Infect. Immun. 72:1832-1836.
30. Yeaman, M. R., J. C. Lee, and A. S. Bayer. 1999. Experimental Candida endocarditis, p. 1709-1720. In O. Zak and M. E. Sande (ed.), Handbook of animal model infections. Academic Press, London, United Kingdom.